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SUMMARY. The present work evaluated the protective effect of aqueous extract of Phyllanthus orbicu-
laris against the mutagenicity of γ-radiation. The extract activity was determined in pre- and post-treat-
ment procedures using Salmonella reversion assay. In either case, the plant extract protected bacterial
cells against the mutations induced by γ-radiation, suggesting that it contains antimutagenic compounds
which confer protection by at least two different mechanisms: i) as antioxidants targeting the oxidative
mutagens induced by γ-radiation and ii) by modulation of the cellular repair enzymes acting on damaged
DNA. The results are discussed in relation to the chemopreventive and radioprotective potential of P. or-
bicularis.  
INTRODUCTION
Radioprotectors are administered to patients
undergoing cancer radiotherapy to reduce the
toxic, mutagenic, and carcinogenic effects of
ionizing radiation on normal cells surrounding
the tumor tissue. In light of the growing interest
in identifying plant and natural compounds with
radioprotective properties, phytochemicals are
of particular interest due to their antiemetic, an-
tiinflammatory, antimicrobial, antioxidant,
hematopoietic, immunostimulant, metal-chelat-
ing, and wound-healing activities 1,2; all of
which are relevant to the mitigation of ionizing-
radiation-induced damage in mammalian sys-
tems. Moreover, these plant-derived compounds
are of particular interest because they are less
toxic than synthetic radioprotectors. As natural
antioxidants, they exhibit a large window of
protection, both pre- and post-irradiation,
against lethality and mutagenesis. 
Aqueous extract of the Cuban endemic plant
Phyllanthus orbicularis has antiviral 3-5 and, as
we have reported, antimutagenic properties.
Thus, in Chinese hamster ovary (CHO) cells, the
extract protects against hydrogen-peroxide-in-
duced clastogenicity 6. In the Salmonella assay,
it protects against mutagenicity by hydrogen
peroxide 7 and exhibit antimutagenic effects
against promutagenic aromatic amines 8,9. Using
the SOS chromotest and other SOS transcription-
al-fusion-based assays, such as recA and umuC
tests, we have shown that aqueous P. orbicu-
laris extract ameliorates γ-radiation-induced
genotoxicity in Escherichia coli cells, most likely
through antioxidant and DNA protection mecha-
nisms, the latter involving DNA repair systems
10,11. Here, we show that the extract protects
Salmonella cells against the mutagenic effect of
γ-radiation, both in pre- and post-irradiation
treatments. Our results provide additional evi-
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dence for the above-mentioned mechanisms in
P. orbicularis mediated radioprotection.
MATERIALS AND METHODS
Bacterial strain and culture
Salmonella enterica Typhimurium strain
TA102 12 was used in this study. Cells were
grown for 16 h at 37 °C with shaking (100 rpm)
in nutrient broth medium (17 g bacteriological
peptone/l, 1 g nutrient powder/l, 2 g yeast ex-
tract/l, 5 g sodium chloride/l). The culture was
then diluted five-fold in fresh medium and
grown under similar conditions until the optical
density at 600 nm (OD600nm) was between 0.9
and 1.2, corresponding to 1–2 × 109 colony-
forming units (cfu)/ml. 
P. orbicularis aqueous extract
P. orbicularis plants were collected from Ca-
jalbana, Pinar del Río, Cuba. The identity of the
specimens was verified and the plants were
stored at the Cuban National Botanical Garden
(No. 7/220). The P. orbicularis aqueous extract
(POE) was obtained from leaves and stems as
described by del Barrio and Parra 4. The quality
and biological stability of the lyophilized extract
were determined as indicated previously 13.
Survival of Salmonella cells after γ-
irradiation 
Samples of cells grown to an OD600 of 0.9
were centrifuged and re-suspended in phos-
phate buffer (0.2 M Na2HPO4/NaH2PO4) at a fi-
nal concentration of 2 × 108 cells/ml, distributed
into glass test tubes, and stored in a refrigerator
until irradiated. Irradiation was carried out at a
temperature of 2 ± 0.5 °C using a Co60 PX-γ-30M
irradiator (Duhna, Russia), with a dose of
20–400 Gy administered at a rate of 33–42
Gy/min (calculated using Fricke’s dosimeter). Ir-
radiated cells were diluted in phosphate buffer;
the dilution range depended on the radiation
dose. Cell dilution samples of 0.1 ml were inoc-
ulated on plates containing nutrient broth medi-
um, and colony-forming units were counted af-
ter 48 h of incubation at 37 °C. 
Antimutagenicity assays
The antimutagenicity of POE against γ-radia-
tion was studied by pre- and post-treatment of
bacterial cells with the extract. In the pre-treat-
ment procedure, bacterial cells were incubated
with POE for 4 h at 8 °C without shaking, after
which it was removed by washing the cells with
distilled water. The cells were then suspended
in phosphate buffer, irradiated with a dose of
100 Gy as indicated above, and assayed by the
standard plate incorporation, carried out as de-
scribed by Maron and Ames 14. In the post-treat-
ment procedure, bacterial cells in phosphate
buffer were irradiated, mixed with POE in top
agar, and then assayed with the standard plate
incorporation test. The POE dose in the assay
was between 0.1 and 2 mg/ml. Controls to ex-
posure with γ-irradiation (100 Gy) and solvent
(distilled water) alone were always included in
each experiment. The number of revertants fol-
lowing each treatment was calculated by averag-
ing a minimum of three independent experi-
ments, with three replicates per experiment. The
antimutagenicity of POE was measured as a sig-
nificant reduction in the number of revertants in
combined treatments (POE + γ-irradiation) and
expressed as percentage of mutagenesis inhibi-
tion:
NRCO – NRE
%MI = 1 x 100
NRI – NRE
where, NRCO is the number of revertants in co-
treated cells (POE + γ-irradiation), NRE is the
number of spontaneous revertants and NRI is
the number of revertants in irradiated cells.
Statistical Analysis
The average values for percent survival and
plate revertants, and the corresponding standard
errors were calculated. The normality of the da-
ta was tested using the Kolmogorov-Smirnov
test. Variance homogeneity and analysis of vari-
ance (ANOVA) tests were also conducted. Mean
values were compared using Student’s t-test. For
all statistical analyses, p < 0.05 was considered
significant. The Statistica v.6 software package 15
was used for all analyses.
RESULTS
First, the survival of strain TA102 following γ-
radiation was determined (Table 1). The dose-
response curve showed that survival decreased
with increasing radiation dose. This decrease
was significant beginning at a dose of 40 Gy.
The median lethal dose (DL50) was 152 Gy. 
The mutagenic effect of γ-radiation on strain
TA102 was then studied to select the optimal ra-
diation dose for the antimutagenesis experi-
ments (Table 1). The doses studied were lower
than the DL50 value and were chosen to avoid a
decrease in the number of revertants because of
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an increase in cell death. The number of in-
duced revertants was found to increase with ra-
diation dose and was significant beginning at a
dose of 20 Gy. Based on these results, a dose of
100 Gy, which yielded double the number of
spontaneous revertants per plate (848 ± 97 vs.
353 ± 40) with a 62% of survival cells, was cho-
sen for the antimutagenic study.
The number of revertants in POE-treated
cells was very similar to that spontaneous rever-
tants number in non-treated cells (Table 2), indi-
cating that concentrations between 0.1 and 2
mg/ml of POE did not lead to mutagenesis in
TA102 strain. The antimutagenic properties of






0 100 ± 0 353 ± 40
20 89 ± 11 n.s. 617 ± 47 *
30 86 ± 14 n.s. 709 ± 31*
40 80 ± 9 * 779 ± 58 *
50 70 ± 12 * 831 ± 70 *
100 62 ± 7 * 848 ± 97 *
200 33 ± 10 * ND
300 22 ± 6 * ND
400 7 ± 3 * ND
Table 1. Survival and mutagenicity of Salmonella
strain TA102 treated with γ-radiation †, Average values
from at least three independent assays with three
replicates each and the corresponding standard error
are given. *, Significant differences with respect to
non-irradiated cell (p < 0.05) were founded using Stu-
dent’s t-test. n.s, Not significant. ND, not determined.
Number of revertants/plate †
(Percentage of Mutagenesis Inhibition)
Pre-incubation procedure Post-incubation procedure
0 0 286 ± 44 256 ± 43 
0.1 0 225 ± 31 225 ± 31 
0.1 100 255 ± 65 (87) * 430 ± 43 (50) *
0.5 0 252 ± 53 252 ± 53 
0.5 100 400 ± 78 (54) * 610 ± 56 (0) n.s.
1.0 0 258 ± 48 258 ± 48
1.0 100 539 ± 124 (0) n.s. 541 ± 66 (18) n.s.
2.0 0 261 ± 30 261 ± 30
2.0 100 519 ± 91 (0) n.s. 532 ± 55 (21) n.s.
0 100 533 ± 74 605 ± 47 
Table 2. Antimutagenicity of Phyllanthus orbicularis extracts (POE) against γ-radiation, as measured in
Salmonella strain TA102. †, Average values from at least three independent assays with three replicates each and
the corresponding standard error are given. The percentage of mutagenesis inhibition (%MI) in combined treat-
ments (POE + γ-irradiation) is given in parentheses. *, A significant difference respect to irradiated cells (p <
0.05) was founded using Student’s t-test. n.s., Not significant. 
Dose of POE
(mg/ml)
Dose of γ-rays 
(Gy)
2. In the pre-treatment procedure, POE pro-
duced a significant decrease in the number of
induced revertants at doses of 0.1 and 0.5
mg/ml (%MI = 87 and 54%, respectively) but not
at higher doses. When the extract was added af-
ter irradiation of the cells (post-treatment proce-
dure), the number of induced revertants de-
creased significantly at a dose of 0.1 mg
POE/plate (% MI = 50%).
DISCUSSION
This study focused on the antimutagenic ef-
fect of POE in γ-irradiated cells. Two different
incubation procedures, pre- and post-irradiation,
were tested. The basis of the pre-incubation as-
say was that oxygen radicals produced by γ-ra-
diation have a very short lifetime; therefore, the
antimutagenic effect of POE against oxidative
mutation should be evident if the extract is al-
ready present during the irradiation. Under this
experimental condition, doses of POE ≤ 0.5
mg/ml significantly decreased the mutagenic ef-
fects induced by γ-radiation. In previously re-
ported studies with similar experimental condi-
tions, a protective effect was also observed with
mutagenic aromatic amines 8 and with hydrogen
peroxide 7. The results obtained with the pre-
treatment procedure indicated that the extract’s
antioxidant activity is important in its antimuta-
genic mechanism of action against γ-radiation,
as was previously shown for hydrogen peroxide
6,7. Antioxidant activity against the oxidative
DNA damage produced by γ-radiation has also
been demonstrated for other species of the
genus Phyllanthus, e.g., P. emblica 16,17.  
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However, interestingly, POE was also an-
timutagenic in the post-treatment procedure, at
a dose of 0.1 mg/plate (% MI = 50%). This find-
ing suggests a mechanism of action other than
antioxidant activity. In previous studies 11, we
showed post-irradiation DNA protection by POE
in a SOS chromotest assay. The antigenotoxic
effect detected in that experiment was explained
by assuming that some component of the plant
extract stimulates or facilitates the action of
DNA repair enzymes, since diminished E. coli
SOS induction following γ-irradiation may well
be interpreted as a reduction in cellular DNA
damage through DNA repair activity. The an-
timutagenic effect of POE detected in the post-
irradiation experiments described here supports
the hypothesis that the extract contains bioan-
timutagenic compounds that facilitate the repair
of DNA damage induced by γ-radiation. Al-
though there are clear differences between the
endpoints of the SOS chromotest and the
Salmonella reversion assay 18, our results and
those previously reported 11 point to similar
modes of action in DNA radioprotection by POE
in Escherichia coli and Salmonella typhimurium
cells.
A preliminary phytochemical characteriza-
tion of POE detected flavonoids, alkaloids,
coumarins, saponins, aminoacids, anthocyani-
dins, mucilages, triterpenes and/or steroids, re-
ducing substances, pyrocatecholic tannins, bitter
and astringent agents, glycosides, and quinones
13. Several of these classes of compounds may
have antimutagenic properties. In a bioassay-as-
sisted fractionation of POE, we identified the an-
timutagenic compound (bis-2,4-di-tert-butylphe-
nol), active against hydrogen peroxide (Ferrer et
al., results not published). The compound may
also be effective against the oxidative DNA
damage induced by γ-radiation; but this remains
to be determined. 
Different species of the genus Phyllanthus,
including P. amarus, P. emblica, and P. urinar-
ia, have been shown to exert chemopreventive,
anticarcinogenic, and antitumor effects in animal
models 19-29. Based on its negative genotoxicity
data 30 and antigenotoxic properties against aro-
matic amines 8,9, hydrogen peroxide 6,7 and γ-ra-
diation 11, and present work, P. orbicularis
clearly has broad-ranging therapeutic potential
as a source of chemopreventive and radiopro-
tective compounds. 
In conclusion, the present work presented
evidence of the ability of POE to protect against
γ-radiation-induced mutagenesis both in pre-
and post-irradiation treatments. Demonstration
of post-irradiation DNA protection against DNA
damage conducive to mutation by POE supports
the idea that compounds of this plant extract
could be used as a chemopreventive or thera-
peutic agent after radiotherapy in order to mini-
mize the development of secondary tumors.
Thus, the information derived from this and sim-
ilar studies could be applied to optimize the use
of radioprotective agents in cancer therapy.
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